Robin Ali is a Professor of Human Molecular Genetics at King's College London. Previous he served as a professor at UCL Institute of Ophthalmology. He is also Theme Leader for Gene Therapy at NIHR Biomedical Research Centre, Moorfields Eye Hospital and Director of the Wolfson Gene Therapy Unit. He is Visiting Professor of Ophthalmology at Kellogg Eye Center, University of Michigan and Founder and Chief Scientific Officer of MeiraGTx. Ali’s research interests focused on development of gene and cell therapy for the treatment of retinal disorders.

Robin Ali obtained a degree in Genetics from UCL in 1988 and his PhD from UCL in 1993 working on developing transgenic mouse models. After a postdoc at the MRC National institute for Medical Research.